China Universal Asset Management Co., Ltd. Arcellx, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,466 shares of ACLX stock, worth $723,733. This represents 0.08% of its overall portfolio holdings.
Number of Shares
11,466
Previous 10,339
10.9%
Holding current value
$723,733
Previous $863,000
1.16%
% of portfolio
0.08%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding ACLX
# of Institutions
224Shares Held
44.7MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$276 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$236 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$222 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$220 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$210 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.77B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...